HIG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Hartford Insurance Group Inc (HIG) is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company has shown strong financial performance and positive analyst sentiment, the lack of immediate trading signals, insider selling, and potential short-term price decline suggest waiting for a better entry point.
The technical indicators show a mixed picture. The MACD is positive and contracting, suggesting bullish momentum, and the moving averages (SMA_5 > SMA_20 > SMA_200) are bullish. However, the RSI is neutral at 69.317, and the stock is trading near its resistance level (R1: 143.661), which could limit upside potential in the short term. Additionally, similar candlestick patterns suggest a 70% chance of a -4.11% decline in the next week and -5.19% in the next month.
Strong financial performance in Q4 2025, with revenue up 6.59% YoY, net income up 32.78% YoY, and EPS up 38.19% YoY.
Positive analyst sentiment with multiple price target increases and buy/overweight ratings.
Hedge funds are significantly increasing their positions, with a 324.87% increase in buying over the last quarter.
Insiders are selling heavily, with a 4250.90% increase in selling activity over the last month.
Options data shows bearish sentiment with a high Option Volume Put-Call Ratio of 4.
Stock trend analysis indicates a potential short-term decline of -4.11% in the next week and -5.19% in the next month.
In Q4 2025, Hartford Insurance Group Inc reported strong financial growth. Revenue increased by 6.59% YoY to $7.34 billion, net income rose by 32.78% YoY to $1.13 billion, and EPS grew by 38.19% YoY to 3.98. These results indicate robust profitability and operational efficiency.
Analysts are generally positive on HIG. Keefe Bruyette, Cantor Fitzgerald, UBS, and Wells Fargo have raised price targets and maintain Outperform or Overweight ratings, citing sustained premium growth, share buybacks, and stable underwriting margins. However, some analysts like Citi and Morgan Stanley maintain Neutral or Equal Weight ratings, highlighting potential headwinds in broader commercial lines margins and a softening insurance cycle.
